Stocks · Health care · Pharmaceutical Preparations

AGIOS PHARMACEUTICALS, INC.

AGIO Clue Score43

United States Fiscal year ends December CIK 0001439222 Results filed 5 Nov 2026

Add to watchlist

What the insiders did Net buying

Insider

Date

Role

Action

Price

Amount

David P Schenkein

13 Nov 2019

Director

Buy

8,064

$31.00

$249.98K

Jacqualyn A Fouse

13 Nov 2019

Chief Executive Officer

Buy

40,322

$31.00

$1.25M

Celgene Corp /De/

12 Nov 2019

10% owner

Buy

403,225

$31.00

$12.50M

Showing 250 of 423 transactions. The figures above use every one of them.

Form 4 filings counted 484

Amendments (4/A) skipped 10

Filings about a different issuer 0

Unreadable filings 0

Joint filings 3

Sales on a Rule 10b5-1 plan 47

Sales straight out of an exercise 250

Sales at will 107

Transactions with no price 0

Shares from compensation/vesting 2,824,750

Sales filed before the plan box existed 96

History held since 30 Jul 2013